Barricaid® Annular Closure
-
Spine
Intrinsic Therapeutics Announces New Category 1 CPT Code for Bone Anchored Annular Closure, including the Barricaid® Annular Closure Device, to Treat Patients Undergoing Lumbar Discectomy for Herniated Discs
BOSTON, Oct. 24, 2024 /PRNewswire/ — Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy to…
Read More » -
Hospitals
Intrinsic Therapeutics announces the Filing of PMA Application for its Barricaid® Anular Closure Device for Lumbar Discectomy Patients.
BOSTON, Dec. 21, 2016 /PRNewswire/ — Intrinsic Therapeutics, Inc. announced today that the filing of its Pre-Market Approval (PMA) application with the Food…
Read More » -
Intrinsic Enrolls First Patient in Barricaid® Trial
WOBURN, Mass., Feb. 17, 2011 /PRNewswire/ — Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that…
Read More »